Australian Deeptech Funding Q1 2026: The Picture That's Emerging


Australian deeptech funding through Q1 2026 produced fewer headlines than 2024 or 2025 but more meaningful data. With three months of disclosed transactions to read against the prior year, the picture that’s emerging is genuinely useful — and genuinely uneven.

Total disclosed deeptech investment for the quarter sits in roughly the same range as Q1 2025 in dollar terms, but the composition has shifted significantly. Mega rounds — single transactions above $50 million — are proportionally smaller than they were a year ago. Mid-stage rounds in the $5 to $20 million bracket are proportionally larger. The implication is that the mid-band of the Australian deeptech ecosystem is functioning, even if the headline-generating end is quieter.

Where the money actually went

Three sectors absorbed roughly 60 per cent of Q1 disclosed deeptech investment.

Quantum computing and quantum sensing continued to take a meaningful share, though down from the post-Silicon Quantum Computing Series B peak in mid-2024. The dollar volume is real but the count of deals is small — a handful of well-known names attracted most of the capital. The breadth of the funded quantum cohort hasn’t grown in the way some commentators were predicting. The interesting story underneath the headlines is the strengthening of academic spinout pipelines from Sydney, Melbourne and Brisbane, which suggests the sector composition will diversify over the medium term even if the quarterly numbers don’t show it yet.

Climate tech and energy storage attracted a notable concentration of mid-stage capital, with several Australian battery, hydrogen, and renewable energy hardware companies closing rounds in the $8 to $25 million range. The deal count is the strongest signal — there’s genuine breadth in this sector now, not just a handful of marquee names. Government-aligned funding mechanisms are visibly active in the cap tables, which is consistent with the policy direction but worth flagging for anyone reading these numbers as pure private market signal.

Defence and dual-use technology is the category that has most clearly grown over the prior year, both in dollar volume and deal count. The Australian defence industrial policy environment has produced new funding mechanisms, the procurement signals are clearer, and a meaningful number of early-stage Australian companies are now playing in this space. The capital being deployed is higher conviction than the broader deeptech average — these are companies with funded customer pipelines, not companies hoping to find a market.

Where the money quietly didn’t go

Several categories that were active 12 to 24 months ago saw notably less Q1 activity.

Web3 and blockchain infrastructure has effectively flatlined as a deeptech category in Australia. The capital that was being raised under that label in 2022-23 has either rotated to other sectors or exited the local market. The handful of remaining deals are in narrow vertical applications, not in foundational infrastructure.

Generic AI infrastructure plays have softened. The Australian capital appetite for AI-labelled deeptech has narrowed to either application-layer companies with clear traction or genuinely novel research-led companies with unique IP. The middle ground of “AI infrastructure for [vertical]” has gotten harder to fund. This isn’t unique to Australia; it reflects a broader global pattern of capital getting more selective in the AI deeptech category.

Quantum software and quantum applications layer companies — distinct from quantum hardware — saw less Q1 activity than expected. The thesis that hardware-agnostic quantum software would be the early commercial layer hasn’t played out at the pace some investors expected, and the dollar deployment has been correspondingly cautious.

What the Q1 data tells us

Three readings come out of the data.

First, Australian deeptech is functioning but selective. The mid-stage capacity is real and capital is finding the better companies. The frothy end is quieter, which probably reflects sensible market discipline rather than structural weakness.

Second, government-aligned capital is now a genuine factor in the Australian deeptech market. CSIRO Innovation Fund, MRFF-aligned health deeptech, defence industrial mechanisms, and state-level innovation funds are visible in cap tables in ways that they weren’t in 2022. The implications for capital availability are positive. The implications for sector direction are worth reading carefully — capital with policy alignment will tend to flow to policy-aligned outcomes.

Third, exits remain the unsolved problem. The IPO window for deeptech companies is essentially closed, and trade sales to international acquirers remain the dominant path to liquidity. The Q1 disclosed M&A volume in the deeptech category was thin, and most of it was at the smaller end. Without a clearer exit story, Series C and later capital will continue to be hard to attract domestically. Foreign capital is filling some of that gap, but with the policy implications that come with foreign ownership of strategically significant Australian deeptech.

What I’d watch for the rest of 2026

Three things over the next two quarters.

The IPO market signals from Australian growth-stage deeptech companies. If even one or two credible Australian deeptech IPOs land in the back half of 2026, the Series B and C funding environment will materially improve. If they don’t, the late-stage capital squeeze gets worse.

The flow of international capital into Australian quantum and defence categories. These are the two sectors where Australian companies have genuinely differentiated capability and where the strategic capital is most likely to come from. Tracking who’s investing matters as much as how much.

The depth of the early-stage pipeline. The disclosed Q1 2026 numbers measure deals that closed; the more interesting metric is how many deeptech companies are at the start of their funding journeys, which institutions are seeding them, and what the conversion rates look like to Series A. The answers to those questions will shape 2027 and 2028 more than the current quarter shapes anything immediate.

The headline story is quieter than 2024-25. The underlying story is healthier in important ways and weaker in others. Both can be true.